Medication-Assisted Treatment Consulting
Medication-Assisted Treatment Consulting from NT Health Consulting provides physician-led guidance to design, launch, or refine MAT programs that are clinically effective, compliant with evolving regulations, and resilient under legal scrutiny. As board-certified addiction medicine specialists with frontline and executive experience, we understand both the clinical nuances of buprenorphine, methadone, and naltrexone care and the operational pressures surrounding them.
We start by reviewing your current MAT model - patient selection, induction and stabilization protocols, dosing practices, urine drug testing, psychosocial supports, diversion controls, and follow-up systems. We identify where practice reflects current evidence and where gaps, variability, or documentation weaknesses may translate into safety concerns, payer friction, or liability.
Working with your clinical, compliance, and legal teams, we refine or develop protocols that address high-risk areas: co-prescribing with benzodiazepines or other sedatives, transitions between levels of care, pregnancy and postpartum management, handling of relapse, and criteria for taper or discharge. We ensure that patient education, consent, and shared decision-making are adequately documented in a way that is meaningful clinically and defensible if challenged.
For organizations scaling MAT across multiple sites or telehealth platforms, we help standardize approaches while allowing room for clinical judgment. This includes clear expectations for supervision, communication across teams, and integration with behavioral health and primary care.
Our recommendations are grounded in addiction medicine standards, payer expectations, and the realities of busy clinical settings. Every engagement is structured for secure remote collaboration, with practical tools - protocol language, documentation templates, and training priorities - that your teams can implement to strengthen both patient outcomes and program defensibility.
We start by reviewing your current MAT model - patient selection, induction and stabilization protocols, dosing practices, urine drug testing, psychosocial supports, diversion controls, and follow-up systems. We identify where practice reflects current evidence and where gaps, variability, or documentation weaknesses may translate into safety concerns, payer friction, or liability.
Working with your clinical, compliance, and legal teams, we refine or develop protocols that address high-risk areas: co-prescribing with benzodiazepines or other sedatives, transitions between levels of care, pregnancy and postpartum management, handling of relapse, and criteria for taper or discharge. We ensure that patient education, consent, and shared decision-making are adequately documented in a way that is meaningful clinically and defensible if challenged.
For organizations scaling MAT across multiple sites or telehealth platforms, we help standardize approaches while allowing room for clinical judgment. This includes clear expectations for supervision, communication across teams, and integration with behavioral health and primary care.
Our recommendations are grounded in addiction medicine standards, payer expectations, and the realities of busy clinical settings. Every engagement is structured for secure remote collaboration, with practical tools - protocol language, documentation templates, and training priorities - that your teams can implement to strengthen both patient outcomes and program defensibility.
Request A Consultation
An email will be sent to the owner